IFNG and non-small cell lung carcinoma: IFNγ/IL-10 ratio was nonetheless found reduced in NSCLC patients compared with the COPD group, supporting the notion that the TH1 response in NSCLC patients was turned down, whereas the TH2 response was more prominent.